Literature DB >> 11193593

Cytokine-induced alteration of the epithelial barrier to food antigens in disease.

M Heyman1, J F Desjeux.   

Abstract

The alteration of the intestinal epithelial barrier is often a consequence of various intestinal diseases but may also be the starting point of these diseases. Undigested food antigens are transported across the intestinal epithelium by a transcytotic mechanism, including a processing within the enterocytes, and leading to the passage of intact proteins, peptides, and amino acids to the underlying mucosa. Inflammation and infection lead to the upregulation of the transport and processing of food proteins; for example, IFN gamma increases the rate of transcytosis and alters, like TNF alpha, the tight junction permeability. Infection of gastric digestive epithelia with Helicobacter pylori also increases the antigenic load transmitted to the underlying immune system by inhibiting the enterocytic lysosomal degradation of proteins. In allergic diseases, such as cow's milk allergy, TNF alpha may be involved in the intestinal dysfunction and the associated enteropathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193593     DOI: 10.1111/j.1749-6632.2000.tb05258.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

Review 1.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 2.  Intestinal barrier function: molecular regulation and disease pathogenesis.

Authors:  Katherine R Groschwitz; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2009-07       Impact factor: 10.793

Review 3.  The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease.

Authors:  Kathryn L Pothoven; Robert P Schleimer
Journal:  Tissue Barriers       Date:  2017-06-13

Review 4.  The immunopathogenesis of cow's milk protein allergy (CMPA).

Authors:  Giovanna Vitaliti; Vitaliti Giovanna; Carla Cimino; Cimino Carla; Alfina Coco; Coco Alfina; Andrea Domenico Praticò; Praticò Andrea Domenico; Elena Lionetti; Lionetti Elena
Journal:  Ital J Pediatr       Date:  2012-07-23       Impact factor: 2.638

5.  Peptides' role in autism with emphasis on exorphins.

Authors:  Karl L Reichelt; Dag Tveiten; Anne-Mari Knivsberg; Gunnar Brønstad
Journal:  Microb Ecol Health Dis       Date:  2012-08-24

6.  Induction of tumor necrosis factor (TNF) release from subtypes of T cells by agonists of proteinase activated receptors.

Authors:  Haiwei Yang; Tao Li; Jifu Wei; Huiyun Zhang; Shaoheng He
Journal:  Mediators Inflamm       Date:  2013-12-16       Impact factor: 4.711

7.  A systematic review and meta-analysis of the benefits of a gluten-free diet and/or casein-free diet for children with autism spectrum disorder.

Authors:  Liuliu Quan; Xinjie Xu; Yonghong Cui; Heze Han; Robert L Hendren; Lidan Zhao; Xin You
Journal:  Nutr Rev       Date:  2022-04-08       Impact factor: 7.110

8.  Levels of inflammatory cytokines from peripheral blood mononuclear cells of children with cow's milk protein allergy.

Authors:  Maria D'Apolito; Angelo Campanozzi; Ida Giardino; Massimo Pettoello-Mantovani
Journal:  Turk Pediatri Ars       Date:  2017-12-01

9.  The uptake of soluble and particulate antigens by epithelial cells in the mouse small intestine.

Authors:  Savannah E Howe; Duane J Lickteig; Kyle N Plunkett; Jan S Ryerse; Vjollca Konjufca
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

10.  Metronidazole or Cotrimoxazole therapy is associated with a decrease in intestinal bioavailability of common antiretroviral drugs.

Authors:  Flore Dossou-Yovo; Godefroy Mamadou; Imar Djibrine Soudy; Nicolas Limas-Nzouzi; Joe Miantezila; Jehan-François Desjeux; Bruno Eto
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.